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Parents and adolescents preferences for
asthma control: a best-worst scaling choice
experiment using an orthogonal main
effects design
Wendy J. Ungar1,2*, Anahita Hadioonzadeh1, Mehdi Najafzadeh3, Nicole W. Tsao4, Sharon Dell1,2,5 and Larry D. Lynd4,6
Abstract
Background: The preferences of parents and children with asthma influence their ability to manage a child’s
asthma and achieve good control. Potential differences between parents and adolescents with respect to specific
parameters of asthma control are not considered in clinical asthma guidelines. The objective was to measure and
compare the preferences of parents and adolescents with asthma with regard to asthma control parameters using best
worst scaling (BWS).
Methods: Fifty-two parents of children with asthma and 44 adolescents with asthma participated in a BWS study to
quantify preferences regarding night-time symptoms, wheezing/chest tightening, changes in asthma medications,
emergency visits and physical activity limitations. Conditional logit regression was used to determine each group’s
utility for each level of each asthma control parameter.
Results: Parents displayed the strongest positive preference for the absence of night-time symptoms (β = 2.09,
p < 0.00001) and the strongest negative preference for 10 emergency room visits per year (β = −2.15, p < 0.00001).
Adolescents displayed the strongest positive preference for the absence of physical activity limitations (β = 2.17,
p < 0.00001) and the strongest negative preference for ten physical activity limitations per month (β = −1.97).
Both groups were least concerned with changes to medications.
Conclusion: Parents and adolescents placed different weights on the importance of asthma control parameters
and each group displayed unique preferences. Understanding the relative importance placed on each parameter
by parents and adolescents is essential for designing effective patient-focused disease management plans.
Keywords: Adolescents, Asthma control, Best-worst scaling, Child health, Preferences
Background
Despite the availability of asthma guidelines [1–3],
achieving control continues to be challenging for children,
parents and health providers [4–8]. Research has shown
that adult asthma patients [9, 10] and parents [11, 12]
have unique perceptions of asthma control. Since children
depend on parents/caregivers for access to health services
and use of medications, parental preferences play an im-
portant role in asthma control. The Global Initiative for
Asthma (GINA) recommends consideration of patient
preferences for adults and for children over 5 years as they
relate to treatment choice, peak flow meter use, cost and
other issues related to treatment [2]. The US Expert Panel
Report (EPR) 3 guidelines recommend consideration of
preferences, concerns and school schedules in selection of
treatments for children aged 5 to 11 years and for children
aged 12 years and older [1]. None of the guidelines con-
siders preferences with regard to actual parameters of
asthma control, which may affect adherence to disease
management plans.
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Best-worst scaling (BWS) experiments offer a rigour-
ous method for measuring preferences [13, 14]. In a
BWS study, respondents choose the most and the least
preferred items from a list of three or more attributes
presented in a single task. A questionnaire typically
contains ten to twenty choice tasks with the values of
the attributes changing for each choice task. By analys-
ing the respondents’ selections over a series of choice
tasks, the preferences for each attribute level can be es-
timated statistically [15]. BWS questionnaires are easy
to administer, making this approach ideal for child
health research [16]. The study objectives were to
measure and compare the preferences of parents of
young children with asthma and adolescents with
asthma regarding attributes of asthma control.
Methods
Item selection
Potential attributes and levels related to asthma control
were initially identified through a literature review. At-
tributes were discussed in two parent focus groups and
one adolescent focus group. Parents and teens were not
related to each other. Focus group participants pre-
sented their views on factors they perceived to be
important in asthma control. Focus groups were audio-
taped and transcripts were coded for recurrent themes.
Factors important for asthma control clustered around
symptoms, medication changes, school and work ab-
sences, physical activity limitations, emergency services,
season and susceptibility to colds. A draft BWS instru-
ment with five asthma control attributes was created
for pilot testing [1–3, 17].
BWS instrument development
As a full factorial design which would encompass all
possible combinations of attribute levels would not be
feasible, a fractional design that included a plausible
array of choice options was created using Sawtooth™
software (Sequim, WA). A subset of these choice tasks
was selected to adhere to BWS design principles to
maximize design efficiency. This included displaying i)
orthogonality which ensures that differences in the levels
of each attribute vared independently over choice sets,
and ii) balance, to confirm that all levels appeared with
equal frequency in the questionnaire [15]. Using an or-
thogonal main effects plan design, a questionnaire with
18 choice tasks was created. To avert respondent fatigue,
this questionnaire was divided into two blocks or ver-
sions, each with nine choice tasks. Each task contained
the same five attributes, with levels that varied across
tasks. Each task asked respondents to choose the most
and least preferred items (Table 1, Additional file 1). The
questionnaire took 10 to 20 minutes to complete.
The draft instrument was pilot-tested in 18 English-
speaking parents of children with clinically diagnosed
asthma and unrelated adolescents with asthma. The
pilot test resulted in minor revisions. The final instru-
ment contained 5 attributes with 3 levels each. The
attributes and levels were: Night-time symptoms (none;
3 days per week; 5 days per week), Wheezing or tightening
of chest (no chest tightening or wheezing; chest tight-
ening or wheezing but it is manageable [does not
worsen]; chest tightening or wheezing and is bother-
some [may worsen]); Changing medication (no changes
needed to medication; more doses or adding on another
asthma medication needed; adding oral steroids for
5 days needed), Emergency visits (no Emergency room
visits; 4 Emergency room visits per year; 10 Emergency
room visits per year) and Participation in physical activ-
ities (no physical activity limitations; 2 limitations per
month; 10 limitations per month). Numeric values for
levels were designated rather than ordinal values (e.g.
never, occasionally and often) so that respondents
would interpret each level in the same way. The use of
extreme values (e.g. Night-time symptoms 5 days per
week, Emergency room visits 10 per year) is useful in
BWS experiments to enable measurement of negative
as well as positive preferences. A reasonable time inter-
val was selected for each attribute (e.g. week, month or
year). For example, an interval of one month was se-
lected for activity limitations as children typically par-
ticipate in organized physical activity on a weekly basis
over several months and parents and teens could there-
fore express their preferences for the indicated levels
without difficulty. Similarly, parents have been shown
to be reliable reporters of asthma emergency room
visits over one year [18] and choosing this interval
allowed for the specification of a wide frequency range.
Table 1 A sample best-worst choice task
Considering the following choices of attributes and their levels, please
indicate which one you consider as the most preferred (best) and which
one you consider as the least preferred (worst) attribute in asthma control.
Please choose only one best and only one worst.
Best Worst
□ Night-time symptoms: □
None
□ Wheezing or tightening of chest: □
Chest tightening or wheezing,
but it is manageable (does not worsen)
□ Changing medication: □
More doses or adding on another medication needed
□ Emergency visits: □
4 Emergency room visits per year
□ Limitation of physical activities: □
10 limitations per month
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Participants
The target populations were parents with a child with
clinically diagnosed asthma between 2 and 12 years of
age or adolescents with asthma aged 12 to 16 years who
had a prescription for an asthma controller in the previous
year. Children with significant respiratory, cardiac, neuro-
logical and congenital conditions, cancer, musculoskeletal
abnormalities and psychological or mental health impair-
ments were excluded. Respondent groups were unrelated
and the same family could participate in only one of the
two surveys. Focus group and pilot study participants
were excluded. Parent and adolescent respondents were
recruited from two outpatient asthma clinics, an asthma
education clinic and through the Asthma Society of
Canada (ASC), a community advocacy organization.
Data collection
Potential subjects were randomly allocated to one of
two BWS questionnaire blocks. Packages containing
an information sheet, the BWS instrument, a parent-
completed demographics questionnaire, and a parent-
completed child health questionnaire were mailed to
interested participants. The demographics questionnaire
captured child age, child sex, parental education, whether
the reporting parent was born in Canada, whether the
child had access to a drug plan and household income.
These items were selected to permit a characterization of
the socioeconomic status of the sample and facilitate com-
parison with other studies. As colds were identified as an
important factor for asthma worsening during the focus
groups, questions related to colds were included in the
health questionnaire. These questions used a 6-month re-
call interval shown to be reliable in previous studies [18].
For adolescents, their parents completed the health and
demographics questionnaires only. The questionnaires
could be completed by mail, phone or online.
Statistical analysis
Data from parent and adolescent samples were analysed
separately. Demographic and health data were analysed
with descriptive statistics using SAS version 9.2 (Carey,
NC). Conditional logit regression with choice as the
dependent variable was used to analyse the BWS data
and generate regression coefficients for attribute levels
using Latent Gold Choice, version 4.5 (Belmont, MA). A
main effects model in which the regression coefficients
represent the strength of preference for the specified
level for each group was constructed. This analysis al-
lows a comparison of preferences for all levels of all at-
tributes relative to a single reference level. Ten physical
activity limitations per month was designated as the ref-
erence level because its utility fell between more pre-
ferred attribute levels (e.g. no night-time symptoms) and
less preferred levels (e.g. ten emergency visits). A
standard error, p value and 95 % confidence intervals
(CI) were calculated for each coefficient based on all
choices within each group, without adjustment for clus-
tering of preferences at the respondent level. The main
effects analysis did not assess statistical interactions be-
tween attribute levels and sociodemographic variables.
Ethics, consent and permissions
The study was approved by the Research Ethics
Boards of The Hospital for Sick Children (Sick Kids),
the University of British Columbia-Providence Health
Care Research Institute, and the William Osler Health
System, Canada (adolescent study only). Completion
of the questionnaires signified informed consent. Par-
ticipants were not asked to consent to making their
data public.
Results
Of 80 packages mailed, 50 parents (63 %) completed
health and demographic questionnaires and 52 (65 %)
completed the choice questionnaire. Of 88 packages
mailed to adolescents, 54 (62 %) parents of adolescents
completed health and demographic questionnaires and 44
adolescents (50 %) completed the choice questionnaire.
Sample characteristics
Parents in both groups were comparable on most
characteristics (Table 2). A higher proportion of par-
ent group respondents received a university education
compared to parents of adolescents. There was a
trend toward greater respiratory health services use in
the parent group. Ninety percent of the children of
the parent sample were using a controller with or
without other medications compared to 85 % in the
adolescent sample. Twenty-six percent of the children
of parent respondents used combination long-acting
beta agonist plus inhaled corticosteroid medications
compared to 59 % of adolescents, however the former
group represents younger children for whom combin-
ation inhalers may not be indicated. The sample dis-
played a symptom frequency, rate of exacerbations
and use of urgent care indicative of moderate to se-
vere asthma for the children of parent participants as
well as the adolescents.
Parents’ reports of physical activity limitations and
the effects of colds on their child’s asthma were simi-
lar for young children and for adolescents (Table 3).
Eighty percent of parents of young children and 76 %
of parents of adolescents with asthma reported their
children being equally or more physically active than
other children of the same age, but just over half re-
ported that their children catch colds, flu or respira-
tory infections more easily. A majority of both groups
reported worsening of asthma due to colds.
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Preferences for asthma control
The regression analysis of parents’ preferences are pre-
sented in Table 4 and plotted in Fig. 1. The results
indicate that parents had the strongest positive prefer-
ence for the absence of night-time symptoms (β = 2.09,
p < 0.00001), which was greater than their preference for
Table 2 Demographic and health characteristics
Characteristic Parents (n = 50) Adolescents (n = 54) P-value
n % n %
Child’s age (years), mean (SD) 7.6 (2.5) 13.5 (1.2) <0.0001
Child of male sex 32 64.0 36 66.7 0.84
Parents born in Canada 27 54.0 31 57.4 0.84
Parental education 0.0255
University or college degree/diploma 38 76.0 31 57.4
Some university or college 7 14.0 8 14.8
Completed high school or less 5 10.0 15 27.8
Family has a drug benefits plan 41 82.0 42 77.8 0.59
Annual household income ($ CDN) 0.43
Less than $60,000 11 22.0 19 35.2
$60,000 to $120,000 17 34.0 16 29.6
Greater than $120,000 15 30.0 6 11.1
Not sure or prefer not to respond 7 14.0 13 24.1
Asthma attacks in last 6 months, mean (SD) 2.6 (3.7) 1.8 (3.6) 0.29
History of other respiratory conditions
Respiratory syncytial virus 8 16.0 1 1.9 0.0134
Croup 15 30.0 5 9.3 0.0116
Symptom frequency in the last month 0.99
None 13 26.0 16 29.6
One to two times per month 14 28.0 15 27.8
One to three times per week 14 28.0 15 27.8
One to four times per day 7 14.0 7 13.0
Other or missing 2 4.0 1 1.9
Night-time asthma symptoms in last month 31 62.0 26 48.1 0.20
≥1 family doctor visit in last 6 months 18 36.0 11 20.4 0.19
≥1 pediatrician visit in last 6 months 13 26.0 9 16.7 0.55
≥1 respiratory specialist visit in last 6 months 35 70.0 36 66.7 0.39
≥1 emergency room visit in last year 13 26.0 16 29.6 0.21
≥1 hospital admission in last year 3 6.0 7 13.0 0.18
Received asthma management or action plan 35 70.0 40 74.1 0.79
Exposed to second-hand smoke in public 6 12.0 10 18.5 0.42
Asthma medications used in last year 0.35
BD monotherapy 2 4.0 4 7.4
ICS monotherapy 4 8.0 1 1.9
BD + ICS or BD + AL 25 50.0 33 61.1
BD + ICS + AL 16 32.0 12 22.2
Oral corticosteroid with or without other asthma medication 2 4.0 4 7.4
Other 1 2.0 0 0.0
Abbreviations: AL anti-leukotriene, BD bronchodilator, ICS inhaled corticosteroid, SD standard deviation. P value from t-test for continuous variables and Fishers
Exact test for categorical variables. Significant results indicated in bold type
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the absence of wheezing or chest tightening, no changes
to medications, no emergency room visits and no phys-
ical activity limitations. Parents’ strongest negative pref-
erence (least favourable) was for 10 emergency room
visits per year (β = −2.15, p < 0.00001) which was much
less preferred than frequent night-time symptoms,
bothersome wheezing or chest tightening, the need to
add oral steroid medications or ten physical activity limi-
tations per month. The spread between the most and
least preferred levels for each attribute is an indication
of the relative importance of that attribute to respon-
dents, given the level options specified in the BWS ques-
tionnaire. The wide magnitude for emergency room
visits suggests that parents strongly distinguished be-
tween zero and ten emergency room visits per year.
Their preferences between the highest and lowest levels
of night-time symptoms, wheezing or chest tightening
and physical activity limitations were similar. Parents
expressed the least difference in their preferences with
regard to the need to make changes to their child’s
asthma medications. While parents expressed a nega-
tive preference for the addition of an oral
corticosteroid (β = −0.20), they were only slightly
more averse to this than to night-time symptoms
three days per week (β = −0.18) or two physical activ-
ity limitations per month (β = −0.14) None of these
three coefficients was statistically significant.
Adolescents’ preferences for asthma control attributes
are presented in Table 4 and Fig. 2. While the strength
of their preference for averting night-time symptoms
was similar to parents, adolescents demonstrated the
strongest positive preference for the absence of physical
activity limitations (β = 2.17, p < 0.00001), which was
greater than their preference for the absence of night-
time symptoms, the absence of wheezing or chest tight-
ening, no changes to medications, and no emergency
room visits. Adolescents’ positive preference for averting
emergency room visits (β = 1.90, p < 0.00001) was similar
to parents (β = 1.82, p < 0.00001). Adolescents’ strongest
negative preference was for ten physical activity limita-
tions per month (β = −1.97) closely followed by ten
emergency room visits per year (β = −1.83, p < 0.00001)
which was less preferred than frequent night-time symp-
toms, bothersome wheezing or chest tightening or the
Table 3 Physical activity and cold symptoms
Characteristic Parents (n = 50) Adolescents (n = 54) P-value
n % n %
Parent report of child’s physical activity compared with other children of same age 0.25
Much more active 13 26.0 17 31.5
Moderately more active 9 18.0 10 18.5
Equally active 18 36.0 14 25.9
Moderately less active 7 14.0 13 24.1
Not sure 3 6.0 0 0.0
Child catches colds, flu or respiratory infections more easily than other children 29 58.0 29 53.7 0.70
Frequency of colds in last 6 months 0.88
Never 4 8.0 5 9.3
1 to 2 times 23 46.0 28 51.9
3 to 4 times 14 28.0 14 25.9
More than 4 times 9 18.0 7 13.0
Number of days cold lasts
3 to 5 days 19 38.0 28 51.9 0.49
6 to 7 days 15 30.0 11 20.4
More than a week 12 24.0 10 18.5
Not applicable 4 8.0 5 9.3
Worsening of asthma due to colds 41 82.0 40 74.1 0.67
Frequency of asthma worsening due to colds in last 6 months 0.41
Never 14 28.0 18 33.3
About half of the times child has a cold 13 26.0 14 25.9
Every time child has a cold 20 40.0 22 40.7
Other 3 6.0 0 0.0
P value from Fishers Exact test
Ungar et al. BMC Pulmonary Medicine  (2015) 15:146 Page 5 of 10
need to add oral steroid medications. The wide spread
between upper and lower levels for physical activity limi-
tations and for emergency room visits suggests that
these two attributes were most important to adolescents,
given the options available. Their preferences for levels
of night-time symptoms and wheezing or chest tighten-
ing were similar. Adolescents had a stronger preference
for no changes to medications compared to parents but
appeared more indifferent than parents with regard to
adding more doses or another medication (β = −0.03)
and adding an oral corticosteroid (β = 0.02).
Discussion
Not only do parents and adolescents have a good under-
standing of the factors that contribute to loss of asthma
control, they have unique preferences with regard to
which asthma control parameters are most important.
Parents of young children with asthma were considered
an important respondent group because asthma fre-
quently presents at a very young age and can be severe,
and parents are responsible for ensuring their children
receive adequate treatment. While their asthma may be
less frequent or severe, adolescents may experience
difficulty attaining asthma control as they express a
growing independence from their parents.
Whereas parents placed the strongest positive prefer-
ence on the absence of night-time symptoms, adoles-
cents felt that the absence of physical activity limitations
was most important. These findings may reflect parents’
beliefs that frequent night-time symptoms may be more
directly related to poor asthma control than other attri-
butes or may in part reflect a desire to avert night-time
awakenings to improve their own sleep. It may also be
possible that parents did not express a stronger prefer-
ence to avert physical activity limitations because they
are often not present when their children engage in or-
ganized physical activity and therefore are not as aware
of the impact of this attribute on asthma control. Ado-
lescents’ strong preference to avert physical activity limi-
tations may be related to a desire to maintain strong
social relationships with peers and avoid stigmatization.
Ten emergency room visits per month was least pre-
ferred by parents, and while adolescents were highly
averse to frequent emergency room visits, they were
most averse to ten physical activity limitations per
month. Both groups placed least emphasis on changes in
medications as an indicator of poor asthma control.
Table 4 Regression coefficients representing preferences of parents and adolescents for attributes of asthma control
Attribute Parents (n = 52) Adolescents (n = 44)
Beta Lower CI Upper CI P-value Beta Lower CI Upper CI P-value
Night Time Symptoms
None 2.09 1.64 2.55 <0.00001 1.91 1.40 2.42 <0.00001
3 days per week −0.18 −0.61 0.24 0.40 −0.25 −0.73 0.23 0.32
5 days per week −0.90 −1.33 −0.46 <0.00001 −1.15 −1.62 −0.69 <0.00001
Wheezing or tightening of chest
None 1.88 1.42 2.34 <0.00001 1.43 0.92 1.94 <0.00001
Manageable 0.68 0.23 1.12 0.00290 0.55 0.05 1.04 0.03000
Bothersome −0.87 −1.29 −0.45 <0.00001 −1.15 −1.61 −0.70 <0.00001
Changing Medication
None 1.02 0.58 1.47 <0.00001 1.26 0.76 1.77 <0.00001
More doses/add medication 0.11 −0.33 0.56 0.62 −0.03 −0.52 0.47 0.92
Add oral steroids for 5 days −0.20 −0.66 0.26 0.39 0.02 −0.49 0.53 0.94
Emergency room visits
None 1.82 1.37 2.28 <0.00001 1.90 1.39 2.41 <0.00001
4 per year −1.14 −1.55 −0.73 <0.00001 −1.17 −1.62 −0.71 <0.00001
10 per year −2.15 −2.58 −1.73 <0.00001 −1.83 −2.28 −1.39 <0.00001
Physical activity limitations
None 1.31 0.85 1.77 <0.00001 2.17 1.66 2.68 <0.00001
2 per month −0.14 −0.60 0.32 0.54 −0.29 −0.78 0.21 0.26
10 per month −1.14 – – – −1.97 – – –
Conditional logit regression was used to analyse the choice data. The coefficients for all attribute levels were estimated relative to the reference level of 10
physical activity limitations per month. The estimated coefficients represent respondents’ average preference weights for a given attribute level relative to the
reference level. R2(0) Goodness of fit for model with no intercept 0.2591 for parent model and 0.2804 for adolescent model
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The parameters of asthma control traditionally fea-
tured in pediatric clinical guidelines include the fre-
quency of day-time and night-time symptoms, school
absences, use of short-acting beta-agonists, and phys-
ical activity limitations [1, 2, 17]. In addition, having
one or more severe exacerbation in the last year or poor
pulmonary function (defined as forced expiratory volume
in 1 second less than 60 % of predicted) are recognized as
modifiable risk factors for poor outcomes. The most re-
cent EPR-3 guidelines attempt to clearly distinguish be-
tween impairment, (i.e. the frequency and intensity of
day-time and night-time symptoms, use of short-acting
beta agonists for symptom relief, lung function, activity
limitations and school absences), and risk of acute ex-
acerbation, disease progression, and drug-related ad-
verse events [1].
The distinction between impairment and risk of ex-
acerbation is useful and the inclusion of multiple param-
eters in each domain underscores the many aspects of
disease expression. However, the guidelines provide no
indication of the relative importance of the listed asthma
control parameters. Common assessment tools such as
the Asthma Therapy Assessment Questionnaire [19]
and the Asthma Control Test [20] assume that each
impairment item listed is equally important and they
assign equal weight to them in scoring. No previous
study has investigated the relative importance of asthma
control parameters. The present study demonstrated
that not only do parents and adolescents place different
weight on individual asthma control parameters, their
preferences differ from each other, with parents’ great-
est concern being frequent emergency room visits, and
adolescents, frequent physical activity limitations. A
study in different samples of parents and adolescents
with asthma using a choice experiment with an alterna-
tive design aimed to determine whether preferences
varied within groups [21]. That study detected two
clear classes of respondents within each respondent
group demonstrating that parents and adolescents with
asthma are not homogeneous with regard to their pref-
erences [21].
Both parents and adolescents displayed the most in-
difference to changes in medications as indicators of
asthma control. Parents had a small positive prefer-
ence for additional doses or new medications and a
slightly negative preference for the need to add an
oral corticosteroid. In contrast, the preferences of ad-
olescents for adding doses, new medication or an oral
Fig. 1 Parent preferences for asthma control. The figure indicates the strength of preference of parents for each of the levels of each asthma
control parameter, with positive values indicating more favoured options. Abbreviations: EV, Emergency room visits; IM, Changing medication;
NTS, Night-time symptoms; PA, Physical activity limitations; WTC, Wheezing or tightening of chest
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corticosteroid were close to zero, reflecting indiffer-
ence relative to frequent activity limitations. This percep-
tion of changes in medications may be quite different than
the views of clinical practitioners who perceive the need
for an oral corticosteroid as an important indicator of
acute loss of asthma control. The most recent Canadian
guidelines recommend that the use of daily controller
therapy be promptly reassessed in any patient requiring
an oral corticosteroid and that these patients be referred
to a specialist in the case of frequent courses of oral corti-
costeroids [3].
The most recent updates to asthma clinical practice
guidelines ask practitioners to consider patient prefer-
ences as part of shared clinical decision-making, but
this is limited to use of devices such as peak flow me-
ters, medication selection and administration, and other
barriers to effective management, such as the cost of
medications. Patient preferences with regard to actual
asthma control parameters are not considered, even
though patients’ and parents’ behaviours, particularly
with regard to medication adherence, are strongly influ-
enced by indicators of impairment, such as activity limita-
tions, and indicators of exacerbation, such as emergency
room visits [22–24]. The current Grading of Recommenda-
tions Assessment, Development and Evaluation (GRADE)
guidelines explicitly recommend the examination of
patients’ values and preferences in the construction of
clinical practice guidelines [25]. The GRADE group rec-
ognizes that patients’ preferences, particularly around de-
sired outcomes, adverse effects and trade-offs between
them, are essential for promulgating recommendations
that are clinically meaningful [25].
For asthma education and management programs to
be effective, parents and adolescents must be willing
partners, and their views and preferences must there-
fore be considered in the design of asthma management
plans. Adolescents represent a particularly vulnerable
group. These individuals possess a growing sense of iden-
tity and need for independence while they cope with
accepting responsibility for managing their asthma [26].
Their desire to conform to peer expectations and a
sense of invulnerability may make them unwilling to
use inhaler devices or perceive the need to manage a
chronic condition. This research demonstrates the im-
portance of studying the preferences of adolescents as
well as the psychosocial factors that influence behav-
iour [24, 26, 27].
The study included several strengths and limitations.
The comparison was not between two patient groups;
rather it contrasted parent preferences with adolescent
patient preferences. As informal caregivers, parents may
have unique preferences that may be unrelated to the
Fig. 2 Adolescent preferences for asthma control. The figure indicates the strength of preference of adolescents for each of the levels of each
asthma control parameter, with positive values indicating more favoured options. Abbreviations: EV, Emergency room visits; IM, Changing medication;
NTS, Night-time symptoms; PA, Physical activity limitations; WTC, Wheezing or tightening of chest
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age of their child. While it would not have been feasible
to directly assess the preferences of children with asthma
aged 2 to 12 years with the BWS instrument, it would
be of interest to survey parents of adolescents with
asthma and compare their preferences with the other
two groups. The samples of parents and adolescents
were not generated randomly however purposive sam-
pling from the community and hospital-based asthma
clinics resulted in samples representing a wide range of
socioeconomic, medical history and asthma severity
characteristics. The sample sizes for parents and adoles-
cents were not large; larger samples would have increased
the statistical efficiency (i.e. reduced the standard errors of
the parameters). However, a high level of statistical effi-
ciency was achieved by ensuring that the instrument dis-
played orthogonality (i.e. the difference in the levels of
each attribute varied independently over choice sets), and
balance, to confirm that all attribute levels appeared with
equal frequency [15]. In addition, measurement error was
minimized by thorough pilot testing and feasibility assess-
ment, and by limiting the number of choice tasks to nine.
The samples were drawn from urban and suburban
communities within and around greater Toronto which
may restrict generalizability to areas where asthma
management practices are different. In the present
study, drug benefits were available to 82 % of parents
and 78 % of adolescents. Therefore, for most respon-
dents a lack of medication insurance was not a factor in
medication adherence. This may not be the case in
other jurisdictions.
Conclusions
This study revealed that parents of young children with
asthma and adolescents with asthma possess unique
preferences with regard to averting night-time symp-
toms, wheezing and chest tightening, changing medication,
emergency room visits and physical activity limitations.
Parents had stronger preferences for averting night-time
symptoms while avoiding frequent physical activity limita-
tion was most important to adolescents. Measuring and
understanding the preferences of key stakeholder groups
such as parents and adolescents is critical to ensuring the
effectiveness of asthma management plans. Incorporating
consideration of parent and patient preferences in the de-
sign of practice guidelines may also improve their uptake
and value. Future research should measure preferences of
additional groups, including parents of adolescents and
health care providers.
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